Bell Investment Advisors, Inc Astrazeneca PLC Transaction History
Bell Investment Advisors, Inc
- $533 Million
- Q4 2024
A detailed history of Bell Investment Advisors, Inc transactions in Astrazeneca PLC stock. As of the latest transaction made, Bell Investment Advisors, Inc holds 132 shares of AZN stock, worth $9,740. This represents 0.0% of its overall portfolio holdings.
Number of Shares
132
Previous 186
29.03%
Holding current value
$9,740
Previous $14,000
42.86%
% of portfolio
0.0%
Previous 0.0%
Shares
12 transactions
Others Institutions Holding AZN
# of Institutions
1,368Shares Held
475MCall Options Held
6.08MPut Options Held
4.44M-
Price T Rowe Associates Inc Baltimore, MD60.4MShares$4.45 Billion0.46% of portfolio
-
Primecap Management CO Pasadena, CA41MShares$3.03 Billion2.12% of portfolio
-
Capital International Investors Los Angeles, CA37.5MShares$2.77 Billion0.48% of portfolio
-
Bank Of America Corp Charlotte, NC24MShares$1.77 Billion0.13% of portfolio
-
Franklin Resources Inc San Mateo, CA19.5MShares$1.44 Billion0.37% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $229B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...